News from the debiopharm group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( RICS:SEBF)

Nov 17, 2008, 04:00 ET

Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions

Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly...

Nov 13, 2008, 16:00 ET

Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer

Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and...

Nov 04, 2008, 11:19 ET

Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding

Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly...

Sep 02, 2008, 01:00 ET

Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment

LAUSANNE, Switzerland, September 2 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

May 15, 2008, 01:00 ET

Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations

LAUSANNE, Switzerland, May 15 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

Apr 14, 2008, 01:00 ET

Debiopharm and Airmid Sign Option and License Agreement for the Development of Debio 0824, an ShK Peptide for Autoimmune Disorders

LAUSANNE, Switzerland, April 14 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Mar 04, 2008, 00:00 ET

Clinical Update - Debio 9902 SR in Alzheimer's Disease

LAUSANNE, Switzerland, March 4 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

Feb 27, 2008, 00:00 ET

Debiopharm and EPFL Establish an Oncology Chair

LAUSANNE, Switzerland, February 27 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

Oct 31, 2007, 01:00 ET

Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories

PARIS and LAUSANNE, Switzerland, Oct. 31 /PRNewswire/ -- Ipsen (Euronext: FR0010259150; IPN) and Debiopharm Group (Debiopharm), a global...

Oct 31, 2007, 01:00 ET

Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology

LAUSANNNE, Switzerland and CHIBA, Japan, October 31 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical...

Oct 08, 2007, 01:00 ET

Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award

LAUSANNE, Switzerland, October 8 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Sep 11, 2007, 01:00 ET

Debiopharm Receives cGMP Certification for Quality Control of its Drug Products

LAUSANNE, Switzerland, September 11 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

Aug 30, 2007, 01:00 ET

The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience

LAUSANNE, Switzerland, August 30 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Jun 11, 2007, 01:00 ET

Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease

LAUSANNE, Switzerland, June 11 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Apr 19, 2007, 01:00 ET

Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment of HCV

LAUSANNE, Switzerland, April 19 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Mar 12, 2007, 01:00 ET

Preclinical Update - Debio-0512 Therapeutic Vaccine for the Treatment of Chronic and Acute Inflammatory Conditions

LAUSANNE, Switzerland, March 12 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Nov 20, 2006, 00:00 ET

2006 Mauvernay Research Excellence Award

LAUSANNE, Switzerland, November 20 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Oct 31, 2006, 00:00 ET

Debiopharm Presents New Data Confirming Anti-HCV Activity of Cyclophilin Inhibitor Debio-025

LAUSANNE, Switzerland, October 31 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Oct 23, 2006, 01:00 ET

Debiopharm Signs International License Agreements for Sanvar(R)

LAUSANNE, Switzerland, October 23 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Oct 16, 2006, 01:00 ET

Debiopharm and Cambridge Antibody Technology Enter Into an Exclusive Agreement to Develop and Market SC-1 for Gastric Carcinomas

LAUSANNE, Switzerland, and CAMBRIDGE, England, October 16 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent...